Cancer Research · 2014 · 53 citations · 46 references
Life SciencesMolecular BiologyOncologyChromatin BiologyChromatin StructureStructural BiologyChromatinChromatin InteractionsHistone ProteinsLigand BindingLong-range Chromatin InteractionsProtein Complex AnalysisAcute LeukemiasLeukemia-associated Fusion GenesMll ComplexesMutational Analysis Of BindingMutational Analysis Of DimerizationNuclear Magnetic Resonance SpectroscopyProtein-protein Interface MappingTernary Complex Formation
Mixed lineage leukemia (MLL) fusion-driven acute leukemias represent a genetically distinct subset of leukemias with poor prognosis. MLL forms a ternary complex with the lens epithelium-derived growth factor (LEDGF/p75) and MENIN. LEDGF/p75, a chromatin reader recognizing H3K36me3 marks, contributes to the association of the MLL multiprotein complex to chromatin. Formation of this complex is critical for the development of MLL leukemia. Available X-ray data represent only a partial structure of the LEDGF/p75-MLL-MENIN complex. Using nuclear magnetic resonance spectroscopy, we identified an additional LEDGF/p75-MLL interface, which overlaps with the binding site of known LEDGF/p75 interactors-HIV-1 integrase, PogZ, and JPO2. Binding of these proteins or MLL to LEDGF/p75 is mutually exclusive. The resolved structure, as well as mutational analysis, shows that the interaction is primarily sustained via two aromatic residues of MLL (F148 and F151). Colony-forming assays in MLL-AF9(+) leukemic cells expressing MLL interaction-defective LEDGF/p75 mutants revealed that this interaction is essential for transformation. Finally, we show that the clonogenic growth of primary murine MLL-AF9-expressing leukemic blasts is selectively impaired upon overexpression of a LEDGF/p75-binding cyclic peptide CP65, originally developed to inhibit the LEDGF/p75-HIV-1 integrase interaction. The newly defined protein-protein interface therefore represents a new target for the development of therapeutics against LEDGF/p75-dependent MLL fusion-driven leukemic disorders. Cancer Res; 74(18); 5139-51. ©2014 AACR.
46
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Kathrin M. Bernt, Nan Zhu, Amit Sinha et al. · Cancer Cell · 2011 · 893 citations · Full text
hDOT1L Links Histone Methylation to Leukemogenesis
Yuki Okada, Qin Feng, Yi-Hui Lin et al. · Cell · 2005 · 810 citations · Full text